Clinical Trials Directory

Trials / Unknown

UnknownNCT04930120

Assessing the Impact of COVID-19 Patients Long Distance Transfers Between Intensive Care Units

TRANSCOV Cohort. An Epidemiological Study Assessing the Impact of Critically Ill COVID-19 Patients Long Distance Transfers Between Intensive Care Units

Status
Unknown
Phase
Study type
Observational
Enrollment
3,060 (estimated)
Sponsor
Ecole des Hautes Etudes en Santé Publique · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers

Summary

The TRANSCOV cohort is a multicentre observational retrospective study aiming at assessing the health impact of extra regional transfers of critically ill COVID-19 patients.

Detailed description

In spring 2020 four regions of France faced a surge of severe Coronavirus (COVID) patients which threatened to overflow local intensive care units (ICU) capacities. As an emergency response, between 03/13/2020 and 04/10/2020, an estimated 661 patients were transferred from overcrowded ICUs to other French regions and neighbouring countries. The study aims at assessing the impact of these inter-ICU transfers on the short and medium term physical and psychological outcomes in this population of severe COVID 19 patients. All transferred patients between ICUs outside the origin region are invited to take part. For each transfer, up to four control patients will be selected among those admitted in the same ICU during the same period (+/-4 days of transfer date). Clinical data will be extracted from medical records and will include hemodynamic and respiratory parameters, as well as clinical severity scores before, during and after transfer. Data linkage with medico-administrative data will enrich the clinical database and allow follow-up up to one year after initial admission.

Conditions

Interventions

TypeNameDescription
OTHERInter ICU long distance patient transferIndividual or grouped transportation between ICU of severely ill patients using ambulance, plane, helicopter, train or boat, with specialist medical assistance.

Timeline

Start date
2021-03-01
Primary completion
2021-12-31
Completion
2022-12-31
First posted
2021-06-18
Last updated
2021-06-22

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04930120. Inclusion in this directory is not an endorsement.